BRK-B: Stock thesis & analysis

Berkshire remains a high-quality, conservatively levered franchise (32.6% op margin, 12.1% ROE, D/E modest for a financial holding company) trading at 12.7x P/E and 15x P/FCF — a reasonable multiple for the quality on offer. Institutional 13F coverage is absent here largely for structural reasons: BRK-B's enormous float, index-like ownership via Berkshire itself, and its use as a cash-substitute holding make it a poor fit for typical concentrated 13F stock-picking mandates rather than a red flag on the business. Three C-suite insiders committing $250k in personal purchases in the same week is a modest but genuine conviction signal, and a reflationary commodity backdrop (weak dollar, firm oil) plus a neutral sector tilt for diversified financials supports holding a defensive-quality compounder into a late-cycle credit environment where such names are explicitly exempted from the high-beta caveat.

Catalysts to watch

• Q3 2026 earnings release (expected early November 2026) with insurance float and operating earnings update
• Continued insider buying disclosures reinforcing management conviction
• Potential capital deployment announcement (buyback acceleration or new equity stake) given large cash position

Key risks

• Succession risk as capital allocation transitions away from Buffett-era leadership
• Large cash hoard implies opportunity cost if reinvestment pace lags in a strong-multiple market
• Insurance/reinsurance segment exposed to catastrophe loss volatility
• Valuation score of 55.7/100 suggests limited multiple re-rating upside versus peers

What would change the view

• Stock breaks below $455.00 (approx -10% from entry, below recent consolidation support)
• Operating margin falls below 25% for two consecutive quarters, signaling insurance/underwriting deterioration
• Berkshire discloses a major capital allocation misstep (e.g., large equity stake write-down >5% of book value in a single quarter)